Wolverine Asset Management’s CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va CCAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,683
Closed -$17K 2744
2021
Q4
$17K Buy
+1,683
New +$17.6K ﹤0.01% 1765
2021
Q1
Sell
-900
Closed -$10K 2405
2020
Q4
$10K Hold
900
﹤0.01% 1504
2020
Q3
$9K Sell
900
-199,100
-100% -$2.04M ﹤0.01% 1474
2020
Q2
$2.01M Sell
200,000
-500,000
-71% -$4.97M 0.02% 391
2020
Q1
$6.9M Buy
+700,000
New +$6.99M 0.1% 159

Wolverine Asset Management's CCAC.U Position: Q1 2022 in Review

Wolverine Asset Management sold out of CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va (CCAC.U) in Q1 2022, closing a stake of 1,683 shares — an estimated $17K sold.

Wolverine Asset Management first reported a position in CCAC.U in Q1 2020 and held it in 5 quarters. The position peaked at $6.9M in Q1 2020. 0 funds tracked by Wall St. Rank hold CCAC.U as of Q1 2022.

  • Wolverine Asset Management reported no remaining CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va position as of Q1 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 1,683 CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va shares in Q1 2022, an estimated $17K.
  • Wolverine Asset Management first reported a position in CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va in Q1 2020 and held it in 5 quarters.
  • Wolverine Asset Management's CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va position peaked at $6.9M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va as of Q1 2022.

Based on Wolverine Asset Management's 13F filing for Q1 2022, filed 4 May 2022.